A deep dive into the risks of fluoroquinolone antibiotics, what may cause fluoroquinolone toxicity, and the negative side effects of these medications by Dr. Mark Ghalili, a board-certified internal medicine physician who personally experienced a severe adverse reaction to Cipro.
Fluoroquinolone toxicity refers to serious, sometimes permanent side effects that can occur from taking fluoroquinolone antibiotics like Ciprofloxacin (Cipro Toxicity), Levofloxacin (Levaquin), and Moxifloxacin (Avelox). These adverse effects can impact multiple body systems simultaneously and may persist long after stopping the antibiotic.
In 2016, the FDA strengthened its warnings about fluoroquinolones, stating these antibiotics should only be used when no safer alternatives exist because “the risk of serious side effects generally outweighs the benefits” for routine infections like UTIs and sinus infections.
Fluoroquinolone-Associated Disability (FQAD) is the clinical term used to describe toxicity affecting at least two body systems (neurological, musculoskeletal, psychiatric, or cardiovascular) for 30 days or more after stopping the medication. Patients often refer to this experience as being “floxed.”
Fluoroquinolone antibiotics are designed to kill bacteria, but in susceptible individuals, they may also disrupt mitochondria, connective tissue, and the nervous system.
This is why symptoms often become systemic instead of isolated to one area. Patients may experience tendon pain, neuropathy, brain fog, insomnia, heart palpitations, fatigue, anxiety, and digestive issues all at the same time.
One of the most confusing aspects of fluoroquinolone toxicity is that symptoms can fluctuate, spread, or appear later. Many patients are told their labs are normal or that their symptoms are anxiety-related, which is why the condition is frequently missed or dismissed.
There does not appear to be one single mechanism that explains every case of fluoroquinolone toxicity.
Researchers have investigated several potential mechanisms, including mitochondrial dysfunction, oxidative stress, connective tissue injury, and effects on the nervous system.
In my experience treating patients with fluoroquinolone toxicity, however, I also pay close attention to the circumstances surrounding the exposure.
How many previous courses of fluoroquinolones has the patient taken? What other medications were being used? What was their health like beforehand? Were they exercising heavily during or after the prescription? Did subtle symptoms occur after an earlier course before a more severe reaction developed?
This helps explain one of the most common questions I hear:
Why can two people take the same antibiotic and have completely different reactions?
The answer is likely more complicated than the dose alone. The drug exposure, previous exposures, individual susceptibility, medication combinations, physical stress, and other patient-specific factors may all influence how someone responds.
One of the mechanisms I pay particular attention to is mitochondrial dysfunction.
Mitochondria are responsible for producing cellular energy. When mitochondrial function becomes impaired, patients may experience fatigue, muscle weakness, exercise intolerance, neurological symptoms, and widespread systemic dysfunction.
Fluoroquinolones have been studied for their potential effects on mitochondrial function and oxidative stress. When normal cellular energy production becomes disrupted, the consequences may be widespread.
This may help explain why patients with severe reactions can experience combinations of:
This is one reason I don’t view severe fluoroquinolone toxicity as simply tendon pain or an isolated medication side effect. In some patients, multiple systems appear to be affected simultaneously.
Dr. Ghalili uses the Jenga analogy to help patients understand fluoroquinolone toxicity progression.
Imagine your mitochondrial function as a Jenga tower. Each fluoroquinolone exposure removes blocks from the foundation. Initially, the tower remains stable despite some missing pieces.
One exposure may remove a block, but the tower remains standing. Another exposure removes another block, and you may still feel relatively normal. Then another course or contributing stressor removes a critical block, and suddenly the tower falls.
This is how I think about patients who tell me:
“I’ve taken Cipro before and I was fine. Why did this happen to me this time?”
In my clinical experience, previous exposure can matter. Some patients may take one course or even several courses before experiencing a severe reaction. I believe there can be a cumulative component in susceptible patients, where repeated exposures and other stressors eventually push the body beyond a threshold.
That is why I don’t only ask about the prescription immediately preceding the patient’s symptoms. I want to understand their entire medication and exposure history.
Not every patient who takes a fluoroquinolone develops toxicity. However, some individuals may be more susceptible to severe or prolonged reactions.
Potential factors that may influence susceptibility include:
In my practice, this is why I don’t look at a fluoroquinolone prescription in isolation. I want to know what else was happening in that patient’s body before, during, and after the exposure.
One of the defining characteristics of fluoroquinolone toxicity is how unrelated the symptoms can initially appear.
One patient might experience Achilles tendon pain, burning neuropathy, insomnia, anxiety, fatigue, brain fog, and muscle weakness. At first glance, those may look like completely different medical problems.
However, mitochondria are present throughout the body, connective tissue is widespread, and the nervous system influences nearly every organ system.
Fluoroquinolones have also been associated with tendon and connective tissue injury, which may help explain why some patients experience tendon pain, joint instability, or even tendon rupture after exposure.
Some patients also develop symptoms involving the nervous system, including neuropathy, tingling, burning sensations, insomnia, anxiety, or cognitive dysfunction.
Mitochondrial dysfunction and oxidative stress have also been investigated as possible contributors to the broader pattern of toxicity. This may help explain why a severe reaction can feel like several different conditions appearing at once.
Neurological symptoms can be among the most frightening aspects of fluoroquinolone toxicity.
Patients may experience:
Fluoroquinolones are known to be associated with peripheral neuropathy and central nervous system side effects. Researchers have also examined their effects on neurotransmitter activity, including GABA-related pathways.
In my own experience and in patients I have treated, neurological symptoms can sometimes occur alongside tendon, muscular, and systemic symptoms rather than appearing as an isolated problem.
Patients understandably ask:
“If the antibiotic is out of my system, why am I still getting worse?”
The presence of a medication in the bloodstream and the biological effects associated with an adverse drug reaction are not necessarily the same thing.
If fluoroquinolone exposure has already contributed to mitochondrial dysfunction, oxidative stress, nerve injury, or connective tissue damage, symptoms may continue after the medication itself has been discontinued.
Physical activity can become particularly important when tendons and connective tissues are involved.
Some patients continue running, lifting weights, playing sports, or exercising because they do not yet realize their tissues may be vulnerable. Additional mechanical stress on an already affected tendon may contribute to worsening symptoms or injury.
This is one reason symptoms that continue or appear after a prescription has ended should not automatically be dismissed simply because the medication is no longer being taken.
There is no single presentation of fluoroquinolone toxicity.
Some patients primarily experience tendon and musculoskeletal problems. Others develop neuropathy, burning sensations, insomnia, anxiety, cognitive problems, or other neurological symptoms. Some develop symptoms across multiple systems.
In my clinical experience, the pattern may be influenced by the patient’s previous health, concurrent medications, previous exposures, physical activity, and individual susceptibility.
For example, a patient who continues intense physical activity while a tendon is vulnerable may place additional stress on the Achilles tendon or another affected structure.
This doesn’t mean exercise caused the toxicity. It means the same medication exposure may manifest differently depending on the patient and what was happening in their body at the time.
Many floxed patients become frightened when symptoms evolve or shift over time. A patient may initially experience tendon pain, only to later develop fatigue, insomnia, neuropathy, brain fog, or autonomic symptoms.
Others notice periods of improvement followed by sudden “crashes” or flare-ups triggered by stress, illness, overexertion, repeat antibiotic exposure, steroids, or poor sleep.
This unpredictability is one reason fluoroquinolone toxicity is frequently misunderstood. Symptoms often do not follow the pattern of a typical injury or illness.
One of the most frustrating parts of fluoroquinolone toxicity is that many patients do not look obviously ill from the outside. Standard lab work may not fully explain what they are feeling. Imaging may not capture the full extent of the dysfunction. As a result, many people spend months or years searching for answers.
In Dr. Ghalili’s experience, the pattern matters. A history of fluoroquinolone exposure followed by a new combination of tendon pain, neuropathy, fatigue, insomnia, cognitive changes, anxiety, and physical decline should not be brushed off.
This is especially important for patients who have been labeled with broad diagnoses without a thorough medication history.
Most routine bloodwork and imaging studies are not designed to detect mitochondrial dysfunction, oxidative stress, subtle nerve injury, or widespread connective tissue dysfunction.
Dr. Ghalili explains this to patients using the example of two cotton sheets.
Imagine one sheet with extremely dense, strong fibers and another that has lost a significant amount of its structural strength. From across the room, they both still look like sheets. But when you place stress on them, they may behave very differently.
The same general concept can help explain why imaging may not always account for the severity of what a patient is feeling. Routine imaging may not capture every microscopic or functional change occurring within tissue.
This is why Dr. Ghalili does not evaluate suspected fluoroquinolone toxicity based on one MRI or laboratory result. He looks at the entire clinical picture:
What medication was taken? When was it taken? What symptoms appeared afterward? How did those symptoms progress? Were there previous exposures? What other medications and physical stressors occurred around the same time?
The timeline matters.
There is no single test that can definitively diagnose fluoroquinolone toxicity.
In most cases, diagnosis is based on a careful review of your medical history, particularly prior exposure to fluoroquinolone antibiotics, along with the pattern and timing of symptoms.
Standard lab tests and imaging may appear normal, even when patients are experiencing significant symptoms such as neuropathy, tendon pain, fatigue, or cognitive changes.
In some cases, additional testing may be used to evaluate broader patterns that could be contributing to symptoms, such as:
However, these tests do not confirm fluoroquinolone toxicity on their own. The most important factor is recognizing the clinical pattern and understanding how symptoms developed after antibiotic exposure.
Fluoroquinolone toxicity does not always follow a predictable timeline.
Some patients notice symptoms during the course of the antibiotic. Others experience a delayed reaction that develops days or even weeks after stopping the medication.
In certain cases, symptoms may worsen over time or after repeat exposure, which can make it difficult to connect the reaction back to the original prescription.
Over the past two decades, the U.S. Food and Drug Administration has issued multiple safety warnings regarding fluoroquinolone antibiotics, reflecting growing concerns about their potential for serious and sometimes long-lasting side effects.
Key FDA updates include:
In its 2016 safety communication, the FDA specifically recommended reserving fluoroquinolones for patients who do not have alternative treatment options for conditions such as:
The agency concluded that for these common conditions, the potential risks may outweigh the expected benefits in certain cases.
Fluoroquinolones are a class of antibiotics that include both generic and brand name formulations:
Oral Fluoroquinolones: Ciprofloxacin (Cipro, Cipro XR), Levofloxacin (Levaquin), Moxifloxacin (Avelox), Ofloxacin (Floxin), Norfloxacin (Noroxin), Gemifloxacin (Factive), Delafloxacin (Baxdela)
Injectable Fluoroquinolones: Ciprofloxacin IV, Levofloxacin IV, Moxifloxacin IV
Topical Fluoroquinolones (eye/ear drops): Ciprofloxacin (Ciloxan), Ofloxacin (Ocuflox, Floxin Otic), Levofloxacin (Quixin, Iquix)
Even topical formulations can cause systemic toxicity in sensitive individuals.
Fluoroquinolone’s Cipro and Levaquin can cause serious damage to your central nervous system, potentially inflicting brain injuries and dysfunctions that affect your mental state. They disrupt mitochondrial function, damage nerves, and cause severe oxidative stress. Common side effects of fluoroquinolone toxicity include:
Many patients diagnosed with fibromyalgia, chronic fatigue syndrome, or other unexplained conditions may actually be suffering from unrecognized fluoroquinolone toxicity.
As a board-certified internal medicine physician, I never imagined that taking Cipro would leave me paralyzed and wheelchair-bound.
I suffered from neuropathy, muscle wasting, seizures, and cognitive impairment, all from an antibiotic that was supposed to help me. Traditional medicine had no answers, so I turned to regenerative medicine, where I discovered the root causes of fluoroquinolone toxicity and how to reverse its effects.
My journey was featured on CBS and I won a local Emmy for Best Health Story. Today, I am fully recovered, and have dedicated my practice, Regenerative Medicine LA, to helping others heal from fluoroquinolone toxicity. If you’ve been floxed, know that recovery is possible.
One of the biggest things I’ve learned is to look beyond the last pill.
When I evaluate someone who believes they have been floxed, I look at the cumulative picture.
Previous antibiotic exposure matters. Other medications may matter. Genetics and differences in metabolism may matter. Physical stress may matter. The patient’s health before exposure matters.
And the fact that someone previously tolerated Cipro or another fluoroquinolone does not necessarily tell us how they will respond to another course.
Every patient’s story is different. My job is to reconstruct that story and understand why this particular person developed this particular combination of symptoms.
Recovery from fluoroquinolone toxicity varies widely from person to person. Some patients improve within months, while others require a much longer recovery process depending on the severity of nervous system involvement, tendon injury, mitochondrial dysfunction, and overall health status.
In Dr. Ghalili’s experience, recovery is rarely linear. Many patients experience periods of improvement, setbacks, and symptom flares before gradually rebuilding function over time.
While some patients continue to experience long-term symptoms, many others regain substantial quality of life with proper support, careful lifestyle modifications, and individualized treatment strategies.
For patients whose primary question is “I’ve been floxed. What do I do now?” read our complete guide: Floxed? Here’s How to Get Better.
Recovery from fluoroquinolone toxicity is rarely about one quick fix. Most patients need a thoughtful, personalized strategy that looks at the whole person.
Depending on the patient, care may involve:
Dr. Ghalili does not use a one-size-fits-all protocol. Every case is different, and treatment is tailored accordingly. Learn more about our fluoroquinolone toxicity treatment program.
Fluoroquinolones are antibiotics that work by interfering with bacterial DNA replication through inhibition of DNA gyrase and topoisomerase enzymes. They have also been studied for their potential effects on mitochondrial function, oxidative stress, magnesium balance, and connective tissue.
There is no single mechanism known to explain every case. Research has investigated mitochondrial dysfunction, oxidative stress, connective tissue injury, and effects involving the nervous system. Individual susceptibility, previous exposure, concurrent medications, and other factors may also help explain why reactions vary between patients.
Previous tolerance does not guarantee that every future exposure will produce the same response. In Dr. Ghalili’s clinical experience, some patients appear to experience a cumulative effect. He describes this using the Jenga analogy: several blocks can be removed before the tower finally becomes unstable.
Serious adverse reactions have been reported following fluoroquinolone exposure, and the amount of exposure before symptoms appear can vary considerably between patients. A patient does not necessarily need a long history of fluoroquinolone use before experiencing an adverse reaction.
Stopping the medication does not necessarily mean that its associated biological effects immediately disappear. If an adverse reaction has already affected tendons, nerves, connective tissue, or cellular function, symptoms may persist or evolve after the medication has been discontinued.
Routine bloodwork and imaging do not measure every type of cellular, neurological, or microscopic tissue dysfunction. This is why Dr. Ghalili considers the timing and pattern of symptoms alongside the patient’s medication history rather than relying on a single normal test.
The FDA has warned that systemic fluoroquinolones can be associated with disabling and potentially permanent serious side effects involving multiple body systems. Outcomes vary considerably between patients.
The FDA has issued multiple safety communications and boxed warnings regarding serious adverse effects associated with fluoroquinolone antibiotics, including tendon rupture, peripheral neuropathy, central nervous system effects, and other potentially disabling adverse reactions.
“Floxed” is an informal term commonly used by patients to describe significant adverse effects following fluoroquinolone exposure. Fluoroquinolone-Associated Disability, or FQAD, is terminology used in the medical literature to describe persistent disabling adverse effects involving multiple systems following fluoroquinolone exposure.
Anti-Aging, Regenerative, & Integrative Medicine located in Los Angeles, CA
My final piece of advice is to never lose hope. I have witnessed the most incredible transformations of people thinking they will always be living in a wheelchair only to see them thrive and life live again. Do not ever give up, our bodies are powerful healing machines that can overcome any obstacle.
I ask for you to watch my lecture on fluoroquinolone toxicity in order to educate yourself on this condition, in addition to the countless testimonials of lives we have changed through treatment.
If you’ve been floxed, there is a path forward. Dr. Ghalili’s team is here to guide you through recovery with personalized care and proven results.
Schedule your consultation at Regenerative Medicine LA today. You don’t have to go through this alone.
